Author

Alexander Christides

Observed names: A Christides, Alex Christides, Christides, Alexander

Observed institutions: University Hospitals Birmingham NHS Foundation Trust, Western General Hospital, Public Health England, National Institute for Health and Care Research, University of Oxford, Public Health Scotland, National Records of Scotland, Nepal Health Research Council, Oxford University Clinical Research Unit, Intensive Care National Audit & Research Centre, Oxford University Clinical Research Unit Indonesia, Euan MacDonald Centre for Motor Neuron Disease Research, University of Edinburgh

ORCID: 0000-0002-9476-9827

Observed ORCID: 0000-0002-9476-9827

OpenAlex ID: A5010978466

Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Eugenia Abaleke, Mustafa Abbas, et al. · The Lancet · 533

Convalescent plasma in patients admitted to hospital with COVID-19 (RECOVERY): a randomised controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 493

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 369

Baricitinib in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial and updated meta-analysis

2022 · Obbina Abani, Ali Abbas, et al. · The Lancet · 324

Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2021 · Obbina Abani, Ali Abbas, et al. · The Lancet · 290

Higher dose corticosteroids in patients admitted to hospital with COVID-19 who are hypoxic but not requiring ventilatory support (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · Obbina Abani, Ali Abbas, et al. · The Lancet · 129

Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2023 · O Abani, A Abbas, et al. · The Lancet Diabetes & Endocrinology · 41

Immunomodulatory therapy in children with paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV-2 (PIMS-TS, MIS-C; RECOVERY): a randomised, controlled, open-label, platform trial

2024 · Saul N Faust, Richard Haynes, et al. · The Lancet Child & Adolescent Health · 39

Molnupiravir or nirmatrelvir–ritonavir plus usual care versus usual care alone in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases · 12

A landscape review of the published research output relating to respiratory syncytial virus (RSV) in North & Central America and Europe between 2011-2015

2019 · Amir Kirolos, Alex Christides, et al. · Journal of Global Health · 11

Exploratory study to evaluate the acceptability of a wearable accelerometer to assess motor progression in motor neuron disease

2024 · Emily Beswick, Alexander Christides, et al. · Journal of Neurology · 5

Building a Systematic Online Living Evidence Summary of COVID-19 Research

2021 · Kaitlyn Hair, Emily S. Sena, et al. · Journal of EAHIL · 4

Sotrovimab versus usual care in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

2025 · O Abani, A Abbas, et al. · The Lancet Infectious Diseases

172 Impact of age on interventions and survival in people with motor neuron disease in Scotland

2022 · Alexander Christides, Alexander Symonds, et al. · Journal of Neurology Neurosurgery & Psychiatry

Works count: 15

Citation count: 2,249

H-index: 10

I10-index: 10